MCT is proud to be successfully running a Polio Vaccine study with 1,119 patients randomized within 5 months and targeting around 3,000 patients by March…
Onxeo has engaged MCT (Regional CRO specialized on Middle East and Africa) to expand “Relieve” phase III HCC study in 3 Middle East countries (Lebanon,…
